Literature DB >> 19710329

Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations.

H N Kim1, R D Harrington, H M Crane, S Dhanireddy, T H Dellit, D H Spach.   

Abstract

Immunization with hepatitis B (HBV) vaccine is recommended for all HIV-infected individuals without immunity to HBV. This patient population, however, has relatively poor HBV vaccine responses. Factors associated with this impaired HBV vaccine response in HIV-infected individuals may include older age, uncontrolled HIV replication, and low nadir CD4 cell count. Postvaccination testing for HBV surface antibody is recommended and vaccine non-responders should undergo repeat immunization with a full series. The benefit of double dosage, the appropriate strategy for HIV-infected patients with isolated HBV core antibody and the timing and number of vaccinations in persons with advanced immunosuppression on highly active antiretroviral therapy remain controversial areas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19710329     DOI: 10.1258/ijsa.2009.009126

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  26 in total

Review 1.  Immunization of HIV infected children.

Authors:  Jagdish Chandra; Dinesh Yadav
Journal:  Indian J Pediatr       Date:  2012-02-10       Impact factor: 1.967

Review 2.  Hepatitis B virus vaccination in HIV-infected people: A review.

Authors:  François-Xavier Catherine; Lionel Piroth
Journal:  Hum Vaccin Immunother       Date:  2017-02-16       Impact factor: 3.452

3.  Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta.

Authors:  Carmen Pittman; Sabrina Plitt; Ted Birse; Karen Doucette; Barbara Romanowski; Rya Cooper; Stan Houston; Stephen Shafran; Ameeta E Singh
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

Review 4.  Vaccination in HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Mark R Wallace
Journal:  AIDS Patient Care STDS       Date:  2014-07-16       Impact factor: 5.078

Review 5.  HBV and HIV co-infection: Impact on liver pathobiology and therapeutic approaches.

Authors:  Mohammad Khalid Parvez
Journal:  World J Hepatol       Date:  2015-01-27

6.  Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy.

Authors:  Edione C Reis; Lais T da Silva; Wanessa C da Silva; Alexandre Rios; Alberto J Duarte; Telma M Oshiro; Sergio Crovella; Alessandra Pontillo
Journal:  Hum Vaccin Immunother       Date:  2018-05-17       Impact factor: 3.452

7.  Complications of HIV disease and antiretroviral therapy.

Authors:  Anne F Luetkemeyer; Diane V Havlir; Judith S Currier
Journal:  Top Antivir Med       Date:  2011 May-Jun

8.  Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.

Authors:  Timothy Wilkin; Jeannette Y Lee; Shelly Y Lensing; Elizabeth A Stier; Stephen E Goldstone; J Michael Berry; Naomi Jay; David Aboulafia; David L Cohn; Mark H Einstein; Alfred Saah; Ronald T Mitsuyasu; Joel M Palefsky
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

9.  Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.

Authors:  Kellie L Hawkins; Kirsha S Gordon; Myron J Levin; Adriana Weinberg; Catherine Battaglia; Maria C Rodriguez-Barradas; Sheldon T Brown; David Rimland; Amy Justice; Janet Tate; Kristine M Erlandson
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

10.  Adjuvant potential of low dose all-trans retinoic acid during oral typhoid vaccination in Zambian men.

Authors:  M M Lisulo; M C Kapulu; R Banda; E Sinkala; V Kayamba; S Sianongo; P Kelly
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.